- Home
- APRE vs FMST Comparison
APRE vs FMST Comparison
Compare APRE & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- FMST
- Stock Information
- Founded
- APRE 2006
- FMST 2005
- Country
- APRE United States
- FMST Canada
- Employees
- APRE N/A
- FMST N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- FMST Other Metals and Minerals
- Sector
- APRE Health Care
- FMST Basic Materials
- Exchange
- APRE Nasdaq
- FMST Nasdaq
- Market Cap
- APRE 9.7M
- FMST 7.1M
- IPO Year
- APRE 2019
- FMST N/A
- Fundamental
- Price
- APRE $1.65
- FMST $1.01
- Analyst Decision
- APRE Strong Buy
- FMST
- Analyst Count
- APRE 2
- FMST 0
- Target Price
- APRE $15.50
- FMST N/A
- AVG Volume (30 Days)
- APRE 17.1K
- FMST 241.5K
- Earning Date
- APRE 05-20-2025
- FMST 01-01-0001
- Dividend Yield
- APRE N/A
- FMST N/A
- EPS Growth
- APRE N/A
- FMST N/A
- EPS
- APRE N/A
- FMST N/A
- Revenue
- APRE $1,502,581.00
- FMST N/A
- Revenue This Year
- APRE N/A
- FMST N/A
- Revenue Next Year
- APRE N/A
- FMST N/A
- P/E Ratio
- APRE N/A
- FMST N/A
- Revenue Growth
- APRE 157.63
- FMST N/A
- 52 Week Low
- APRE $1.41
- FMST $0.55
- 52 Week High
- APRE $5.90
- FMST $3.30
- Technical
- Relative Strength Index (RSI)
- APRE 41.84
- FMST 60.54
- Support Level
- APRE $1.67
- FMST $0.91
- Resistance Level
- APRE $1.99
- FMST $1.23
- Average True Range (ATR)
- APRE 0.14
- FMST 0.13
- MACD
- APRE 0.04
- FMST 0.04
- Stochastic Oscillator
- APRE 41.55
- FMST 63.93
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.